Business
Covid-19 treatment: Gilead Sciences urged to study drug that showed promise with cats – The Guardian
GS-441524 has been used to treat a coronavirus in cats but activists accuse company of pushing remdesivir to boost profit
Activists are calling on the pharmaceutical firm Gilead Sciences to study a drug for the treatment of Covid-19 that showed promise in curing cats of a coronavirus.
The drug, called GS-441524, is chemically related to remdesivir, an antiviral also made by Gilead, and one of the only treatments to successfully shorten the duration of Covid-19 recovery.
GS-441524 has also attracted attention for its promise to treat another potential coronavirus feline infectious peritonitis, or FIP. The drug has…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News23 hours agoDingoes bite 3 women on K’gari
-
Noosa News15 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs
-
Noosa News23 hours agoNoosa MP calls for solutions to curb reckless electric bike usage